246 related articles for article (PubMed ID: 32488049)
1. Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis.
Chen Y; Wang Y; Tang R; Yang J; Dou C; Dong Y; Sun D; Zhang C; Zhang L; Tang Y; Dai Q; Luo F; Xu J; Dong S
Cell Death Dis; 2020 Jun; 11(6):414. PubMed ID: 32488049
[TBL] [Abstract][Full Text] [Related]
2. Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway.
Chen Y; Wang Y; Hu J; Tang Y; Tian Z; Hu W; Zeng F; Tan J; Dai Q; Hou Z; Luo F; Xu J; Dong S
Aging (Albany NY); 2020 Jun; 12(12):11698-11716. PubMed ID: 32527985
[TBL] [Abstract][Full Text] [Related]
3. Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.
Hu B; Wu F; Shi Z; He B; Zhao X; Wu H; Yan S
J Cell Mol Med; 2019 Aug; 23(8):5762-5770. PubMed ID: 31225720
[TBL] [Abstract][Full Text] [Related]
4. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
[TBL] [Abstract][Full Text] [Related]
5. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
6. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis
Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J
FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415
[TBL] [Abstract][Full Text] [Related]
7. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
Meng J; Zhou C; Zhang W; Wang W; He B; Hu B; Jiang G; Wang Y; Hong J; Li S; He J; Yan S; Yan W
J Cell Mol Med; 2019 Oct; 23(10):6730-6743. PubMed ID: 31328430
[TBL] [Abstract][Full Text] [Related]
8. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
9. The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling.
Zhai Z; Qu X; Li H; Yang K; Wan P; Tan L; Ouyang Z; Liu X; Tian B; Xiao F; Wang W; Jiang C; Tang T; Fan Q; Qin A; Dai K
Biomaterials; 2014 Aug; 35(24):6299-310. PubMed ID: 24816285
[TBL] [Abstract][Full Text] [Related]
10. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
[TBL] [Abstract][Full Text] [Related]
11. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.
Cao J; Wang S; Wei C; Lin H; Zhang C; Gao Y; Xu Z; Cheng Z; Sun WC; Wang HB
Int Immunopharmacol; 2021 Jan; 90():107137. PubMed ID: 33199235
[TBL] [Abstract][Full Text] [Related]
12. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.
Wu Z; Wu H; Li C; Fu F; Ding J; Shao S; Li K; Yu X; Su Y; Liang J; Lin X; Yuan G; Zhou J; Song F; Zhao J; Xu J; Liu Q; Xu F
J Cell Physiol; 2019 Aug; 234(10):17812-17823. PubMed ID: 30815894
[TBL] [Abstract][Full Text] [Related]
13. LY411575, a potent γ-secretase inhibitor, suppresses osteoclastogenesis in vitro and LPS-induced calvarial osteolysis in vivo.
Chen X; Chen X; Zhou Z; Qin A; Wang Y; Fan B; Xu W; Zhang S
J Cell Physiol; 2019 Nov; 234(11):20944-20956. PubMed ID: 31020651
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of WKYMVm peptide on inflammatory osteolysis through regulating NF-κB and CD9/gp130/STAT3 signalling pathway.
Hu J; Li X; Chen Y; Han X; Li L; Yang Z; Duan L; Lu H; He Q
J Cell Mol Med; 2020 Jan; 24(2):1893-1905. PubMed ID: 31837208
[TBL] [Abstract][Full Text] [Related]
15. Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway.
Tang W; Xiao L; Ge G; Zhong M; Zhu J; Qin J; Feng C; Zhang W; Bai J; Zhu X; Wei M; Geng D; Wang Z
J Cell Mol Med; 2020 Oct; 24(20):11972-11983. PubMed ID: 32896108
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways.
Liang S; Nian Z; Shi K
Biochem Biophys Res Commun; 2020 Jun; 526(4):1028-1035. PubMed ID: 32321638
[TBL] [Abstract][Full Text] [Related]
17. Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways.
Liu Y; Song FM; Ma ST; Moro A; Feng WY; Liao SJ; Lin XX; Zhao JM; Wang ZY; Xu J; Zhan XL; Liu Q
J Cell Physiol; 2019 Aug; 234(8):13832-13842. PubMed ID: 30637734
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhai ZJ; Li HW; Liu GW; Qu XH; Tian B; Yan W; Lin Z; Tang TT; Qin A; Dai KR
Br J Pharmacol; 2014 Feb; 171(3):663-75. PubMed ID: 24125472
[TBL] [Abstract][Full Text] [Related]
19. Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis in vitro and titanium nanoparticle-induced bone loss in vivo.
Yang C; Zhu K; Yuan X; Zhang X; Qian Y; Cheng T
J Cell Mol Med; 2020 Jan; 24(2):1553-1567. PubMed ID: 31845532
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F
Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
